In our Ryan White-funded clinics, we are nothing if not adaptable and efficient. As a pharmacist in a safety net clinic, I am used to navigating complex care systems. Case in point, our clinic has recently adapted to the sweeping changes to the Florida AIDS Drug Assistance Program (ADAP) and our patients continue to receive high-quality care.
In January 2026, the Florida Department of Health abruptly announced it would cut ADAP income eligibility from 400 percent down to 130 percent of the federal poverty level, discontinue health insurance premium assistance, and remove preferred single-tablet regimens like Biktarvy from the formulary—changes that officially went into effect on March 1, 2026. I understand the state’s urgent need to save money due to a projected budget shortfall, but these abrupt cost-containment measures came at the expense of continuity of care, treatment simplicity, and the stability of the clinical team.
Although on March 24, 2026, the state ultimately signed into law emergency bridge funding restoring the income threshold, and subsequently moved to restore Biktarvy to the formulary as of July 1, 2026. These disruptions sent shock waves through the HIV care continuum and workforce. Specifically, disruptions like these exhaust established providers and discourage trainees from entering the HIV workforce.
HIV clinicians are resilient by profession as the landscape of treatment has rapidly evolved since the beginning of the epidemic, but these ADAP changes to income eligibility, loss of insurance premium assistance, and restrictions on preferred single tablet regimens have pushed more of our time from clinical care to navigating bureaucracy. For a clinical pharmacist, time that was spent on comprehensive medication management or patient counseling is now used for navigating payer systems, manufacturer assistance programs, and pharmacy logistics. For a clinic physician, it means decisions about treatment plans must be adjusted based on bureaucratic decisions, not clinical evidence. Our case managers are burdened by more paperwork rather than focusing on social drivers of health and keeping patients engaged in care.
In our clinic, we are managing the ADAP changes successfully because our interprofessional team is strong. Yet, I see this as an inefficient use of our time, a waste of valuable resources, and it’s leading to burnout. The administrative tax of practicing HIV care is outweighing the clinical focus. Providers will look to fields where they can practice the complexity of medicine, not where they practice bureaucracy.
A more critical issue is how this environment looks to the next generation of HIV care providers. New trainees learn to practice HIV medicine at our clinic. They are smart, eager, and looking for a field where they can make an impact. When they rotate through a Florida Ryan White clinic, they learn a hidden curriculum of problem-solving which has recently been focused on replacing a guideline-recommended preferred HIV therapy with an ADAP-approved workaround. When trainees observe the frustrating and unpredictable policy changes to our specialty, they will naturally look toward a field with a more stable landscape. We can teach trainees how to manage a changing formulary, but we cannot convince them to choose a career path that is volatile. Policies that restrict efficient HIV care raise an active barrier to the young professionals we need entering the HIV workforce.
If we want a robust workforce pipeline for the future of HIV medicine, we need sustainable policies that support clinicians in what they do best — treating patients. Our HIV care teams are strong and capable, but the future of the workforce depends on policies that cut away administrative burden and promote efficiency.
